Disrupting the status quo is no easy feat, especially when you're already a leader in cardiac rhythm management. Yet, Medtronic seems to have achieved just that with its OmniaSecure defibrillation ...
Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), ...
Analysts have been eager to weigh in on the Consumer Goods sector with new ratings on Fevertree Drinks (FQVTF) and Wal-Mart de Mexico SAB de CV (WMMVF). The word on The Street in general, suggests a ...
Background Survival from out-of-hospital cardiac arrest (OHCA) is higher if the arrest is witnessed and occurs during exercise, however, there is contradicting data on prognosis with regards to sex ...
In a 10-patient feasibility study, heart digital twins were used to guide VT ablation. Afterward, VT was noninducible in all patients; at a mean follow-up of 13 months, 8 patients were free of ...
The OmniaSecure lead received FDA approval for left bundle branch area pacing. [Image courtesy of Medtronic] Medtronic (NYSE: MDT) announced today that it received FDA approval for an expanded ...
Axcelis Technologies, Inc. engages in the manufacture of capital equipment for the semiconductor chip manufacturing industry. Its ion implantation systems product line includes high and medium current ...
Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results